Gastric emptying time and gastric motility in patients with Parkinson's disease

Cited by (248)

Items 101–200 of 248

1. Imaging Systemic Dysfunction in Parkinson’s Disease
   Per Borghammer, Karoline Knudsen, David James Brooks · 2016 · Current Neurology and Neuroscience Reports
2. Levodopa–carbidopa intestinal gel in advanced Parkinson’s disease: long-term results from COSMOS
   Alfonso A. Fasano, R. García-Ramos, Tanya Gurevich, Robert Jech, Lars Bergmann, Olga Sánchez‐Soliño, Juan Carlos Parra, Mihaela Adriana Simu · 2023 · Journal of Neurology
3. Low Serum Vitamin D Levels May Contribute to Gastric Dysmotility in de novo Parkinson's Disease
   Ki Young Kwon, Kwang Deog Jo, Moon Kyu Lee, Minyoung Oh, Eyu Nyong Kim, Jinse Park, Ji Sun Kim, Jinyoung Youn, Engseok Oh, Hee-Tae Kim et al. · 2016 · Neurodegenerative Diseases
4. Other Forms of Gastroparesis
   Eamonn M.M. Quigley · 2014 · Gastroenterology Clinics of North America
5. Electrogastrography in Patients with Parkinson’s Disease
   Timna Naftali, N. Gadoth, M. Huberman, Ben Novis · 2005 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
6. Ghrelin prevents levodopa-induced inhibition of gastric emptying and increases circulating levodopa in fasted rats
   Li-Xin Wang, N. Murphy, Andreas Stengel, Miriam Goebel-Stengel, David L. St. Pierre, Nigel T. Maidment, Yvette Taché · 2012 · Neurogastroenterology and Motility
7. Body fat distribution in Parkinson's disease: An MRI-based body fat quantification study
   Denise Bernhardt, Hans‐Peter Müller, Albert Christian Ludolph, Luc Dupuis, Jan Kassubek · 2016 · Parkinsonism & Related Disorders
8. Is there a difference in gastric emptying between Parkinson’s disease patients under long-term l-dopa therapy with and without motor fluctuations? An analysis using the 13C-acetate breath test
   Yuji Tanaka, Tomohiro Kato, Hiroshi Nishida, Hiroshi Araki, Masahiko Murase, Masahito Nagaki, Hisataka Moriwaki, Takashi Inuzuka · 2009 · Journal of Neurology
9. Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson's disease
   Giovanna Levandis, Barbara Balestra, Francesca Siani, V. Rizzo, Cristina Ghezzi, Giulia Ambrosi, Silvia Cerri, Arianna Bonizzi, Riccardo Vicini, Mariapia Vairetti et al. · 2015 · Neurogastroenterology & Motility
10. Review: Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease
    O.K. Sujith, Carol J. Lane · 2009 · Therapeutic Advances in Neurological Disorders
11. Imaging Parkinson’s disease below the neck
    Per Borghammer, Karoline Knudsen, Tatyana Dmitrievna Fedorova, David James Brooks · 2017 · npj Parkinson s Disease
12. Imaging the Autonomic Nervous System in Parkinson’s Disease
    Karoline Knudsen, Per Borghammer · 2018 · Current Neurology and Neuroscience Reports
13. Gastric dysmotility in Parkinson's disease is not caused by alterations of the gastric pacemaker cells
    Konstantin G. Heimrich, Veit Yves Pascal Jacob, Denise Schaller, Andreas Stallmach, Otto Wilhelm Witte, Tino Prell · 2019 · npj Parkinson s Disease
14. Gastric myoelectrical differences between Parkinson's disease and multiple system atrophy
    Yumi Sakakibara, Masato Asahina, Atsuya Suzuki, Takamichi Hattori · 2009 · Movement Disorders
15. Management of Gastrointestinal Symptoms in Parkinson’s Disease
    Trisha Satya Pasricha, Ingrid Guerrero-López, Braden Kuo · 2024 · Journal of Clinical Gastroenterology
16. Amorphous Ropinirole-Loaded Mucoadhesive Buccal Film: A Potential Patient-Friendly Tool to Improve Drug Pharmacokinetic Profile and Effectiveness
    Giulia Di Prima, Giuseppina Campisi, Viviana De · 2020 · Journal of Personalized Medicine
17. Upregulation of β1-adrenoceptors is involved in the formation of gastric dysmotility in the 6-hydroxydopamine rat model of Parkinson's disease
    Song Jin, Li‐Fei Zheng, Xiaoli Zhang, Xiao‐Yan Feng, Ruifang Fan, Lu Zhe Sun, Feng Hong, Yue Zhang, Jin‐Xia Zhu · 2014 · Translational research
18. A review of patient-specific gastrointestinal parameters as a platform for developing in vitro models for predicting the in vivo performance of oral dosage forms in patients with Parkinson’s disease
    Erik Wollmer, Sandra Klein · 2017 · International Journal of Pharmaceutics
19. Gut microbes, ageing & organ function: a chameleon in modern biology?
    Musarrat Maisha Reza, B. Brett Finlay, Sven Pettersson · 2019 · EMBO Molecular Medicine
20. Comparative Bioavailability of 2 Tablet Formulations of Levodopa/Benserazide in Healthy, Fasting Volunteers: A Single-Dose, Randomized-Sequence, Open-Label Crossover Study
    Guillermo Alberto Keller, Paola Czerniuk, Roberto Bertuola, Juan Spatz, Aria Reza Assefi, Guillermo Di Girolamo · 2011 · Clinical Therapeutics
21. In silico modelling of the effect of pyloric intervention procedures on gastric flow and emptying in a stomach with gastroparesis
    Sharun Kuhar, Jung-Hee Seo, Pankaj Jay Pasricha, Rajat Mittal · 2024 · Journal of The Royal Society Interface
22. Radiological analysis of gastrointestinal dysmotility in a model of central nervous dopaminergic degeneration: comparative study with conventional in vivo techniques in the rat.
    G. Vegezzi, Z. Al Harraq, Giovanna Levandis, S. Cerri, F. Blandini, G. Gnudi, F. Miduri, C. Blandizzi, Giuseppe Domenichini, S. Bertoni et al. · 2014 · Journal of pharmacological and toxicological methods
23. Pharmacokinetics of Etilevodopa Compared to Levodopa in Patient's With Parkinson's Disease: An Open-label, Randomized, Crossover Study
    Ruth Djaldetti, Nir Giladi, Sharon Hassin‐Baer, Hertzel Shabtai, Eldad Melamed · 2003 · Clinical Neuropharmacology
24. Movement disorders and cerebrovascular diseases: from pathophysiology to treatment
    Stefano Caproni, Carlo Colosimo · 2016 · Expert Review of Neurotherapeutics
25. Morning Akinesia and the Potential Role of Gastroparesis – Managing Delayed Onset of First Daily Dose of Oral Levodopa in Patients with Parkinson’s Disease
    Stuart Isaacson, К. Ray Chaudhuri · 2013 · European Neurological Review
26. The use of enteral access for continuous delivery of levodopa‐carbidopa in patients with advanced Parkinson’s disease
    Julian Chéron, Jacques M.E. Deviere, Frédéric Supiot, Asuncion Ballarin, Pierre Eisendrath, E Toussaint, Vincent Huberty, Carmen Musala, Daniel Bléro, Arnaud Lemmers et al. · 2016 · United European Gastroenterology Journal
27. Gastric emptying, postprandial blood pressure, glycaemia and splanchnic flow in Parkinson’s disease
    Laurence G. Trahair, Thomas Edmund Kimber, Katerina Flabouris, Michael Horowitz, Karen L. Jones · 2016 · World Journal of Gastroenterology
28. Effect of Nicotine on the Pharmacokinetics of Levodopa
    Win Thiri Kyaw, Masahiro Nagai, Mika Kaneta, Madoka Kubo, Noriko Nishikawa, Tomoaki Tsujii, Hirotaka Iwaki, Masahiro Nomoto · 2013 · Clinical Neuropharmacology
29. Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations
    Richard G. Fiddian-Green · 2007 · Neurology
30. Experimental Dopamine Reuptake Inhibitors in Parkinson’s Disease: A Review of the Evidence
    Thomas H. Müller · 2021 · Journal of Experimental Pharmacology
31. Meta-analysis of Magnetic Marker Monitoring Data to Characterize the Movement of Single Unit Dosage Forms Though the Gastrointestinal Tract Under Fed and Fasting Conditions
    Émilie Hénin, Martin Bergstrand, Werner Weitschies, Mats O. Karlsson · 2015 · Pharmaceutical Research
32. Gut-to-brain spreading of pathology in synucleinopathies: A focus on molecular signalling mediators
    Verena Schmitt, Rebecca Katharina Masanetz, Martin Weidenfeller, Lara Savannah Ebbinghaus, Patrick Süß, Stephan P. Rosshart, Stephan von Hörsten, Friederike Zunke, Jürgen Winkler, Wei Xiang · 2023 · Behavioural Brain Research
33. Preventive effect of rikkunshito on gastric motor function inhibited by l-dopa in rats
    Lixin Wang, Sachiko Mogami, Hiroshi Karasawa, Chihiro Yamada, Seiichi Yakabi, Koji Yakabi, Tomohisa Hattori, Yvette Taché · 2014 · Peptides
34. Motor and non‐motor fluctuations
    Susan Helen Fox, Anthony Edward Lang · 2007 · Handbook of clinical neurology
35. Genetic variants of α‐synuclein are not associated with essential tremor
    Owen A. Ross, Karen N. Conneely, Tao Wang, Carles Vilariño‐Güell, Alexandra I. Soto‐Ortolaza, Alex H. Rajput, Zbigniew K. Wszołek, Ryan J. Uitti, Elan D. Louis, Lorraine N. Clark et al. · 2011 · Movement Disorders
36. Gastrointestinal Issues in Depression, Anxiety, and Neurodegenerative Diseases: A Systematic Review on Pathways and Clinical Targets Implications
    Ian Richard Lucena Andriolo, Bruna Cristina Longo, Dayse Machado de Melo, Márcia María de Souza, Rui Daniel Prediger, Luísa Mota da Silva · 2024 · CNS & Neurological Disorders - Drug Targets
37. Pharmacokinetics of Levodopa and 3-O-Methyldopa in Parkinsonian Patients Treated with Levodopa and Ropinirole and in Patients with Motor Complications
    Urszula Adamiak-Giera, Wojciech Jawień, Anna Pierzchlińska, Monika Anna Białecka, Jan Kobierski, Tomasz Janus, Barbara Gawronska-Szklarz · 2021 · Pharmaceutics
38. Gastric Emptying of Semisolids and Pouch Motility Following Laparoscopic Adjustable Gastric Banding
    Ekaterina Tiktinsky, Leonid Lantsberg, Sophie Lantsberg, Solly S. Mizrahi, Svetlana Agranotvich, Michael D Friger, Boris Kirshtein · 2009 · Obesity Surgery
39. Gut Microorganisms and Neurological Disease Perspectives
    Nairita Ahsan Faruqui, Durdana Hossain Prium, Sadrina Afrin Mowna, Md. Asad Ullah, Yusha Araf, Bishajit Sarkar, Umme Salma Zohora, Mohammad Shahedur Rahman · 2021 · Future Neurology
40. Gastrointestinal Symptoms in Parkinson Disease: Clinical Aspects and Management
    D. Salat-Foix, Christopher N. Andrews, Jon B. Meddings, Oksana Suchowersky · 2011 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
41. Is Gut Dysbiosis an Epicenter of Parkinson’s Disease?
    Charul Rajput, Alika Sarkar, Nidhi Sachan, Neeraj Rawat, Mahendra Pratap Singh · 2021 · Neurochemical Research
42. Activation of α7nAChR Protects Against Gastric Inflammation and Dysmotility in Parkinson’s Disease Rats
    Li Zhou, Li‐Fei Zheng, Xiaoli Zhang, Zhiyong Wang, Yuan-Sheng Yao, Xian Xiu, Chenzhe Liu, Yue Zhang, Xiao‐Yan Feng, Jinxia Zhu · 2021 · Frontiers in Pharmacology
43. Unchanged gastric emptying and visceral perception in early Parkinson's disease after a high caloric test meal
    Epprecht, L., Schreglmann, S. R., Goetze, O., Woitalla, D., Baumann, C. R., Waldvogel, D. · 2015 · Journal of Neurology
44. Gastric emptying in patients with palliative stenting for malignant gastric outlet obstruction.
    Iruru Maetani, Takeo Ukita, Tomoko Tada, Masaki Ikeda, Masahiro Seike, Hitoshi Terada, Ehichi Kohda · 2008 · PubMed
45. Animal Models of Gastrointestinal Problems in Parkinson's Disease
    James G. Greene · 2011 · Journal of Parkinson s Disease
46. Assessments of plasma acyl-ghrelin levels in Parkinson's disease patients treated with deep brain stimulation.
    Wojciech Pietraszko, A. Furgała, Agnieszka Gorecka-Mazur, B. Kwinta, J. Kaszuba-Zwoińska, J. Polak, U. Fiszer, K. Gil, A. Krygowska-Wajs · 2020 · Peptides
47. Effects of dietary factors on levodopa pharmacokinetics
    Nélida Fernández, Juan Jose Garcia, M. José Diez, Ana M. Sahagún, Raquel Díez, Matilde Sierra · 2010 · Expert Opinion on Drug Metabolism & Toxicology
48. The Gut–Brain Axis in Parkinson's Disease
    Virginia Gao, Carl V. Crawford, Jacqueline Burré · 2024 · Cold Spring Harbor Perspectives in Medicine
49. Gastroretentive systems – a proposed strategy to modulate anthocyanin release and absorption for the management of diabetes
    Giovana Bonat Celli, Wilhelmina Kalt, Marianne Su‐Ling Brooks · 2016 · Drug Delivery
50. DA-9701 on gastric motility in patients with Parkinson's disease: A randomized controlled trial
    Cheol Min Shin, Yoon Jin Lee, Jong‐Min Kim, Jee‐Young Lee, Kyung-Joon Kim, Yoon Jin Choi, Nayoung Kim, Dong Ho Lee · 2018 · Parkinsonism & Related Disorders
51. Levodopa Does Not Worsen Gastric Emptying in Parkinson's Disease
    Shunsuke Shiina, Ryuji Sakakibara, Hirokazu Doi, Fuyuki Tateno, Mitsutoshi Sato, Tohru Masaka, Masahiko Kishi, Yohei Tsuyusaki, Tsuyoshi Ogata, Yosuke Aiba et al. · 2015 · Journal of the American Geriatrics Society
52. Characterization of Aspirated Duodenal Fluids from Parkinson’s Disease Patients
    Tom de Waal, Joachim Brouwers, Philippe Berben, Talia R. Flanagan, Jan F. Tack, Wim Vandenberghe, Tim Vanuytsel, Patrick Augustijns · 2023 · Pharmaceutics
53. Levodopa pharmacokinetics -from stomach to brain : A study on patients with Parkinson’s disease
    Maria Nord · 2017 · Linköping University medical dissertations
54. Masticatory function and oral sensorimotor ability in Parkinson's disease: Levodopa on versus off periods
    Giselle Rodrigues Ribeiro, Camila Heitor Campos, Mariana Barbosa Câmara‐Souza, Camilla Fraga do Amaral, Renata Cunha Matheus Rodrigues Garcia · 2018 · Special Care in Dentistry
55. Gastrointestinale Störungen beim idiopathischen Parkinson-Syndrom
    Kelly Del Tredici, Wolfgang H. Jost · 2012 · Der Nervenarzt
56. Pharmacokinetics of Levodopa/Carbidopa Delivered From Gastric‐Retentive Extended‐Release Formulations in Patients With Parkinson's Disease
    Cuiping Chen, Verne E. Cowles, Mike Sweeney, Igor D. Stolyarov, Sergey Nikolaevich Illarioshkin · 2011 · The Journal of Clinical Pharmacology
57. Ingestible Device for Gastric Fluid Sampling
    Nikolaj K. Mandsberg, Gafaru Moro, Mahdi Ghavami, Sandra B. Andersen, Eva Nedergaard de Visser, Mads F. Bertelsen, Martin Steen Mortensen, Tine Rask Licht, Anja Boisen · 2024 · Advanced Materials Technologies
58. Gastric-filling ultrasonography to evaluate gastric motility in patients with Parkinson's disease
    Xianwei Zou, Xiaqing Chen, Yanxia Wen, Xiaofeng Jing, Man Luo, Feng-Yue Xin, Yao Tang, Mengfei Hu, Jian Liu, Fan Xu · 2024 · Frontiers in Neurology
59. Parkinsonism
    Stanley Fahn, Joseph J. Jankovic, Mark Hallett · 2011 · Elsevier eBooks
60. Altered Gut Microbial Load and Immune Activation in a Drosophila Model of Human Tauopathy
    Jerrik Rydbom, Halea Kohl, Vanesa R. Hyde, Kelly M. Lohr · 2021 · Frontiers in Neuroscience
61. Novel pharmacological strategies for motor complications in Parkinson’s disease
    Spyridon Konitsiotis · 2005 · Expert Opinion on Investigational Drugs
62. Effects of Levodopa‐Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson’s Disease: INSIGHTS Study
    Sun Ju Chung, Matilde Calopa, Maria Gabriella Ceravolo, Nicola Tambasco, Angelo Antonini, К. Ray Chaudhuri, Weining Robieson, Olga Sánchez‐Soliño, Cindy Zadikoff, Man Jin et al. · 2022 · Parkinson s Disease
63. Effects of slowed gastrointestinal motility on levodopa pharmacokinetics
    Nélida Fernández, Juan Jose Garcia, M. José Diez, Ana M. Sahagún, Aranzazu González, Raquel Díez, Matilde Sierra · 2010 · Autonomic Neuroscience
64. Open Label Trial of the Efficacy and Safety Profile of Rikkunshito used for the Treatment of Gastrointestinal Symptoms in Patients with Parkinson’s Disease: A Pilot Study
    Koji Yakabi, Naomi Yamaguchi, Shino Ono, Norihito Yoshida, Eriko Hosomi, Kenjiro Hayashi, Mitsuko Ochiai, Kosuke Maezawa, Kyoichi Nomura · 2017 · Current Therapeutic Research
65. Transcutaneous vagus nerve stimulation (tVNS) as a potential therapeutic application for neurodegenerative disorders – A focus on dysautonomia in Parkinson's disease
    Daniel W.K. Ko · 2021 · Autonomic Neuroscience
66. Increased PRR14 and VCAM-1 level in serum of patients with Parkinson's disease
    Huimin Zheng, Tai Wang, Changhe Shi, Liyuan Fan, Yun Su, Yu Fan, Xinwei Li, Jing Yang, Chengyuan Mao, Yuming Xu · 2022 · Frontiers in Neurology
67. An Overview of Gastrointestinal Dysfunction in Parkinsonian Syndromes
    Lauren S. Talman, Delaram Safarpour · 2023 · Seminars in Neurology
68. Gastrointestinal Care of the Parkinson Patient
    John Legge, Nicholas Fleming, Leslie Jameleh Cloud · 2019 · Clinics in Geriatric Medicine
69. Effects of Plantago ovata Husk on Levodopa (with Carbidopa) Bioavailability in Rabbits with Autonomic Gastrointestinal Disorders
    Juan Jose Garcia, Nélida Fernández, Ángela P. Calle, M. José Diez, Ana M. Sahagún, Matilde Sierra · 2009 · Drug Metabolism and Disposition
70. Sexuality and Parkinson's Disease
    Gila Bronner, Vladimir Royter, Amos D. Korczyn, Nir Giladi · 2003 · Humana Press eBooks
71. Dopaminergic neuron loss in mice due to increased levels of wild-type human α-Synuclein only takes place under conditions of accelerated aging
    Ana Pérez‐Villalba, Ma Salomé Sirerol-Piquer, Raúl Soriano‐Cantón, Virginia Folgado-Marco, Azucena Pérez‐Cañamás, Martina Kirstein, Isabel Fariñas, Francisco Pérez‐Sánchez · 2024 · Scientific Reports
72. Esophageal and Gastric Motility Disorders in the Elderly
    Morgan A. Sendzischew Shane, Baharak Moshiree · 2020 · Clinics in Geriatric Medicine
73. Microbiota-mediated effects of Parkinson’s disease medications on Parkinsonian non-motor symptoms in male transgenic mice
    Nina Radisavljevic, Avril Metcalfe‐Roach, Mihai S. Cirstea, Mahebali Tabusi, Tahereh Bozorgmehr, Haggai Bar‐Yoseph, B. Brett Finlay · 2023 · mSphere
74. Objective Measurement and Monitoring of Nonmotor Symptoms in Parkinson's Disease
    Lisa Klingelhoefer, Onanong Jitkritsadakul, Roongroj Bhidayasiri · 2017 · International review of neurobiology
75. GOCOVRI ® (amantadine) extended-release Capsules in Parkinson’s Disease
    Thomas H. Müller · 2021 · Neurodegenerative Disease Management
76. Technique and outcome of percutaneous endoscopic transgastric jejunostomy for continuous infusion of levodopa-carbidopa intestinal gel for treatment of Parkinson’s disease
    Yuji Ishibashi, Yasushi Shimo, Yukinori Yube, Shinichi Oka, Hiroki Egawa, Yoshinori Kohira, Sanae Kaji, Satoshi Kanda, Genko Oyama, Taku Hatano et al. · 2019 · Scandinavian Journal of Gastroenterology
77. Nausea and Vomiting Related to the Central Nervous System Diseases
    Braden Kuo, Prashant Singh · 2016 · Springer eBooks
78. Clinical and pharmacokinetics equivalence of multiple doses of levodopa benserazide generic formulation vs the originator (Madopar)
    Margherita Torti, Jhessica Alessandroni, Daniele Bravi, Miriam Casali, Paola Grassini, Chiara FOSSATI, Cristiano Ialongo, MARCO C. ONOFRJ, Fabiana Giada Radicati, Laura Vacca et al. · 2019 · British Journal of Clinical Pharmacology
79. Neurophysiology of Brain Networks Underlies Symptoms of Parkinson’s Disease: A Basis for Diagnosis and Management
    Martha Teresa Acosta-Mejia, Nelson Villalobos · 2023 · Diagnostics
80. Trastornos autonómicos en enfermedad de Parkinson
    Rodrigo Gómez R, Lorena Hudson, Pablo Venegas · 2011 · Revista médica de Chile
81. Study on absorption sites of quinidine and methotrexate in rat intestine
    Teruo Murakami, Tomoharu Yokooji, Naoko Mori · 2010 · Die Pharmazie
82. Gastric Motility in Parkinson’s Disease is Altered Depending on the Digestive Phase and Does Not Correlate with Patient-Reported Motor Fluctuations
    Laura Ruck, Marcus Michael Unger, Jörg Spiegel, Jan Bürmann, Ulrich Dillmann, Klaus C Fassbender, W. Reith, Martin Backens, Ruben Mühl‐Benninghaus, Umut Yılmaz · 2020 · Journal of Parkinson s Disease
83. Bilateral Subthalamic Nucleus Deep Brain Stimulation Improves Gastric Emptying Time in Parkinson Disease
    Yi Wang, Peng Gao, Xing Zhang, Bo Lv, Ziao Xu, Hongwei Cheng · 2021 · World Neurosurgery
84. Parkinson’s Disease and Gastrointestinal Non Motor Symptoms: Diagnostic and Therapeutic Options – A Practise Guide
    Lisa Klingelhoefer, Heinz Reichmann · 2015 · Journal of Parkinson s Disease
85. Aspiration Prevention and Prophylaxis: Preoperative Considerations
    Mark D. Tasch, Robert K. Stoelting · 2007 · Elsevier eBooks
86. An overview of focused ultrasound as a treatment option for gliomas
    Grace E. Hey, Chloe L. DeYoung, Abeer Dagra, Wiley Braxton Gillam V, Brandon Peter Lucke-Wold · 2025 · Expert Review of Neurotherapeutics
87. Anti-Muscle Specific Kinase (Anti-MuSK) Positive Myasthenia Gravis Overlapping With Parkinson’s Disease: A Challenging Diagnosis
    Mohammed S Albassam, Salman Anwar Thabet, Mohammed Hmoud, Seraj Makkawi · 2021 · Cureus
88. Gastric Emptying Is Not Delayed and Does Not Correlate With Attenuated Postprandial Blood Flow Increase in Medicated Patients With Early Parkinson's Disease
    Hartwig Roman Siebner, Stefan Fuglsang, Christopher Fugl Madelung, Annemette Løkkegaard, Flemming Bendtsen, Jens Dahlgaard Hove, Morten Damgaard, Jan L. Madsen, Hartwig Roman Siebner · 2022 · Frontiers in Neurology
89. Reduced Gastric Contraction in Rapid‐Eye‐Movement Sleep Behavior Disorder and De Novo Parkinson's Disease
    Wolfgang Hermann Oertel, Esther Paule, Theresa Hasemann, Elisabeth Sittig, Marcus Belke, Marcus Michael Unger, Geert Mayer, Rita Werner, Andreas Jansen, Heidi Pape et al. · 2023 · Movement Disorders
90. Molecular dynamics simulation studies on uptake of fipronil sulfone by gut microbiome and its influence on risk for cause of Parkinson’s disease
    Abhay Bhat, M Anushree, Vivek Chandramohan, Sasmita Sabat · 2023 · Molecular Simulation
91. Gastrointestinal dysfunction in idiopathic Parkinsonism: A narrative review
    Mehri Salari, Emad Fayyazi, Omid Mirmosayyeb · 2016 · Journal of Research in Medical Sciences · Retracted
92. Enteral Levodopa Therapy in Advanced Parkinson's Disease with Gastroparesis
    Anil Venkitachalam, Adriana Lazarescu, Oksana Suchowersky · 2015 · Movement Disorders Clinical Practice
93. Symptoms of Parkinson's Disease
    Abdul Qayyum Rana · 2011 · InTech eBooks
94. Management of Gastrointestinal Symptoms in Parkinson’s Disease
    Han‐Lin Chiang, Chin‐Hsien Lin · 2025 · Journal of Central Nervous System Disease
95. Short-Chain Fatty Acids-A Healthy Bus between Gut Microbiota and Organs beyond the Gut
    Ruyue Cao, Yunqing Zeng, Shuhua Li, Peiting Xue, Ming Li · 2022 · Advances in Bioscience and Biotechnology
96. Synergien statt Rivalitäten – die missverstandenen Rollen von kontinuierlicher intrajejunaler Levodopatherapie und Tiefer Hirnstimulation in der Behandlung des Morbus Parkinson – eine Expertenmeinung
    Nils Schröter, Wolfgang H. Jost, Michel Rijntjes, Volker Arnd Coenen, Sergiu Groppa, Bastian Sajonz · 2024 · Fortschritte der Neurologie · Psychiatrie
97. Gastric Dysfunction in Parkinson’s Disease
    Ayal Rozenberg, Tanya Gurevich, Nir Giladi, Amos D. Korczyn · 2012 · Humana Press eBooks
98. Transdermal Drug Delivery in Parkinson’s Disease
    Ronald F. Pfeiffer · 2007 · Aging Health
99. Motility Disorders in the Patient with Neurologic Disease
    Eamonn M.M. Quigley, Seamus O’Mahony, Zaid S. Heetun · 2011 · Gastroenterology Clinics of North America
100. Morning akinesia in Parkinson's disease: challenges and solutions
     Nicola Tambasco, Simone Simoni, Pasquale Nigro, Federico Paolini Paoletti, Erica Marsili, Paolo Calabresi · 2016 · Journal of Parkinsonism and Restless Legs Syndrome